![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Wild, C. (2005): [Herceptin®/Trastuzumab for metastatic breast cancer]. HTA-Newsletter 40: p. 3.
Preview |
PDF (HTA-Newsletter 40)
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
127kB |
Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes
| Item Type: | HTA Newsletter Item |
|---|---|
| Keywords: | Herceptin, trastuzumab, monoclonal antibody, breast cancer, mammary carcinoma, first-line treatment, combination therapy, paclitaxel, anthracycline, effectiveness, costs |
| Subjects: | WP Gynaecology > WP 800-910 Breast WA Public health > WA 309 Women´s health QW Microbiology. Immunology |
| Related URLs: | |
| References: | 1. NHSC/GB 2005: Trastuzumab (Herceptin) for breast cancer – adjuvant early disease. URL: http://pcpoh.bham.ac.uk/publichealth/horizon/PDF_files/ 2005reports/trastuzumab.pdf. 2. HAYES/USA 2004: Trastuzumab (Herceptin(R)) for breast cancer. 3. NCCHTA/GB 2002: The clinical effectiveness of trastuzumab for breast cancer: a systematic review. URL: http://www.ncchta.org/execsumm/summ613.htm. 4. EMEA 2000: Trastuzumab. URL: http://www.emea.eu.int/humandocs/PDFs/EPAR/ Herceptin/177400de1.pdf. |
| Language: | German |
| Number: | 40 |
| Deposited on: | 25 Feb 2008 17:41 |
| Last Modified: | 15 Jul 2020 17:36 |
Repository Staff Only: item control page